Masimo Corporation MASI is well-poised for growth in the coming quarters, courtesy of its strong underlying demand for ...

Masimo Corporation (Nasdaq: MASI) today announced select preliminary financial results for the fourth quarter and full-year ...

MASI posts strong fourth-quarter and full-year 2025 preliminary results with revenue and EPS above estimates, driven by core ...

Masimo reported positive Q4 results. However, investors weren't happy with the company's plan to acquire Sound United. The concerns center on whether Sound United, a consumer tech company, is a good ...

(Reuters) -Masimo said on Monday a potential joint venture partner is prepared to offer $850 million to $950 million for its consumer business, which includes health and audio products. Masimo and the ...

The Irvine-based medical device maker expects Q4 revenue to increase 12% to $411 million and full year revenue to grow 9% to $1.5 billion.

(Reuters) -Masimo said on Thursday that it is prepared to appoint Politan Capital Management's nominee William Jellison as a director on its board, if the activist investor withdraws its other nominee ...

Masimo (NASDAQ: MASI) today announced that its management will participate in the J.P. Morgan 2026 Healthcare Conference on Wednesday, January 14, 2026 at 2:15 p.m. Pacific time. A live webcast of the ...

On January 12, 2026, Masimo announced select preliminary financial results for the fourth quarter and full year 2025, ahead of its full earnings release scheduled for February 26, 2026. For the fourth ...

Masimo (Nasdaq: MASI) is a global technology company that develops and produces a wide array of industry-leading monitoring technologies, including innovative measurements, sensors, patient monitors, ...